PATERNAL EXPOSURE DURING PREGNANCY

This adverse event was reported 864 times

These drugs are most commonly taken by patients reporting PATERNAL EXPOSURE DURING PREGNANCY:

# Drug Count
0 ADALIMUMAB 118
1 OXYCODONE HYDROCHLORIDE 52
2 RISANKIZUMAB-RZAA 45
3 DUPILUMAB 42
4 INFLIXIMAB 38
5 SECUKINUMAB 35
6 UPADACITINIB 32
7 MYCOPHENOLATE MOFETIL 28
8 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 28
9 USTEKINUMAB 21
See all common drugs associated with PATERNAL EXPOSURE DURING PREGNANCY

PATERNAL EXPOSURE DURING PREGNANCY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SALICYLIC ACID 12% 4 0.0021
1 ASTRINGENT 4 0.0021
2 LIQUID CORN AND CALLUS REMOVER 4 0.0021
3 INFLIXIMAB-DYYB 7 0.0020
4 BRODALUMAB 4 0.0019
5 RISDIPLAM 8 0.0019
6 VELAGLUCERASE ALFA 3 0.0015
7 BEDAQUILINE FUMARATE 2 0.0014
8 ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC-VWF-XTEN FUSION PROTEIN-EHTL 2 0.0012
9 GOLIMUMAB 15 0.0012
See all drugs enriched for association with PATERNAL EXPOSURE DURING PREGNANCY